Azenta, Inc. (NASDAQ:AZTA) Shares Purchased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. increased its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 9.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 326,550 shares of the company's stock after purchasing an additional 28,049 shares during the period. Envestnet Asset Management Inc. owned approximately 0.71% of Azenta worth $11,312,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. KLP Kapitalforvaltning AS purchased a new position in Azenta during the fourth quarter worth $530,000. Deutsche Bank AG boosted its stake in Azenta by 28.5% during the fourth quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock worth $210,000 after buying an additional 931 shares during the period. Thrivent Financial for Lutherans boosted its stake in Azenta by 206.5% during the fourth quarter. Thrivent Financial for Lutherans now owns 35,223 shares of the company's stock worth $1,761,000 after buying an additional 23,731 shares during the period. SG Americas Securities LLC boosted its stake in Azenta by 90.6% during the first quarter. SG Americas Securities LLC now owns 30,972 shares of the company's stock worth $1,073,000 after buying an additional 14,719 shares during the period. Finally, Corient Private Wealth LLC boosted its stake in Azenta by 12.7% during the fourth quarter. Corient Private Wealth LLC now owns 28,505 shares of the company's stock worth $1,425,000 after buying an additional 3,221 shares during the period. Institutional investors own 99.08% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on AZTA. Evercore ISI boosted their target price on shares of Azenta from $29.00 to $35.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Stephens began coverage on shares of Azenta in a research note on Tuesday. They set an "equal weight" rating and a $35.00 target price for the company. Finally, Needham & Company LLC lowered their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th.

Azenta Trading Up 5.6%

Shares of AZTA traded up $1.74 during trading hours on Tuesday, reaching $33.06. 197,776 shares of the company traded hands, compared to its average volume of 739,182. The firm has a market cap of $1.51 billion, a price-to-earnings ratio of -23.72 and a beta of 1.64. Azenta, Inc. has a 12-month low of $23.91 and a 12-month high of $63.58. The stock's fifty day moving average price is $29.75 and its 200 day moving average price is $36.35.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. During the same quarter in the previous year, the business earned $0.06 earnings per share. The firm's quarterly revenue was up 5.1% compared to the same quarter last year. On average, research analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.